FDA Inspection
Merck & Co., Inc.Merck & Co., Inc. – FDA Inspection, May 6, 2011
Record Details
This FDA Inspection record concerns Merck & Co., Inc., with an inspection on May 6, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Merck & Co., Inc.
- Inspection Date
- May 6, 2011
- Product Type
- Drugs
View Company Profile
ID · 53acfdec-39e2-456d-954d-d2d5a1791bb0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 723101
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.55(b)New observations, adverse effects and risks
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Merck & Co., Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 29, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 23, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Merck & Co., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.